{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-050060","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.328285+00:00","generated_at":"2026-06-13T21:29:53.219668+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"BiomX stockholders elect three Class III directors and ratify PwC as auditor at 2023 annual meeting","bullets":["Russell Greig, Jonathan Solomon, and Lynne Sullivan elected as Class III directors with >11.8M votes each.","Kesselman & Kesselman (PwC) ratified as independent auditor for fiscal 2023 with 16.46M votes for, 222K against.","Broker non-votes of 4.64M were not counted for director election; no non-votes for auditor ratification.","All proposals passed; no material changes to board composition or auditor relationship."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-050060","json":"https://secwatch.observer/filing/0001213900-23-050060.json","markdown":"https://secwatch.observer/filing/0001213900-23-050060.md","text":"https://secwatch.observer/filing/0001213900-23-050060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023050060/0001213900-23-050060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023050060/ea180636-8k_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T21:29:53.219668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9dd806331bff99b34786d7809e319f8e72dc0850","claim":"BiomX Inc. shareholders approved Election of Class III Directors at the 2023-06-20 meeting.","evidence_excerpt":"Proposal No. 1-Election of Directors The Company’s stockholders voted to elect the following persons to the board of directors of the Company as Class III directors to serve until the 2026 Annual Meetings of Stockholders, respectively: Nominee Votes For Votes Withheld Broker Non-Votes Dr. Russell Greig 11,855,383 188,098 4,641,670 Jonathan Solomon 11,992,906 50,575 4,641,670 Lynne Sullivan 11,854,073 189,408 4,641,670","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023050060/0001213900-23-050060-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-20"}],"fact_type":"shareholder_vote"},{"claim_id":"fe285bd4625152e80dded669a5595fa3c6e9049e","claim":"BiomX Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm For Fiscal Year 2023 at the 2023-06-20 meeting.","evidence_excerpt":"Proposal No. 2-Ratification of Selection of Independent Registered Public Accounting Firm For Fiscal Year 2023 The Company’s stockholders voted to ratify the selection of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm for the fiscal year ending December 31, 2023. Voted For Voted Against Abstain Broker Non-Votes 16,462,401 222,000 750 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023050060/0001213900-23-050060-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-20"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}